أرسل هذا في رسالة قصيرة: Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS)

   _____    _____     _____     ______   __   _   
  / ___//  |  ___||  / ____||  /_   _// | || | || 
  \___ \\  | ||__   / //---`'   -| ||-  | '--' || 
  /    //  | ||__   \ \\___     _| ||_  | .--. || 
 /____//   |_____||  \_____||  /_____// |_|| |_|| 
`-----`    `-----`    `----`   `-----`  `-`  `-`